1,418
Views
2
CrossRef citations to date
0
Altmetric
Hematology

Avatrombopag, a promising novel thrombopoietin receptor agonist for refractory/relapsed/intolerant non-severe aplastic anemia: a phase 2 single-arm clinical trial

, &
Article: 2224044 | Received 06 Jun 2022, Accepted 03 Jun 2023, Published online: 15 Jun 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (2)